GZMK and tuberculosis: These findings indicate that while reduced T cell exhaustion and elevated cytotoxic granule release (e.g., GzmK) may enhance immune activation, they risk exacerbating TB pathology, highlighting the need for cautious therapeutic strategies and further studies to target chronic inflammation without compromising immune regulation.